Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited announced that Dr. Lisa McIntyre will not seek re-election and will step down from the Board on November 5, 2025. Dr. McIntyre has been a significant contributor to the company, particularly as Chair of the Innovation & Development Committee. Her departure prompts the company to begin a search for a new director. Dr. Larry Marshall will take over as Chair of the Innovation & Development Committee. This leadership change reflects Nanosonics’ ongoing commitment to innovation and maintaining strong governance.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products that enhance patient safety and improve healthcare outcomes.
Average Trading Volume: 760,084
Technical Sentiment Signal: Buy
Current Market Cap: A$1.3B
See more insights into NAN stock on TipRanks’ Stock Analysis page.